High Vista Strategies LLC Instil Bio, Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$8.48 - $18.1 $482,520 - $1.03 Million
-56,901 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$15.37 - $22.5 $233,285 - $341,505
-15,178 Reduced 21.06%
56,901 $974,000
Q3 2021

Nov 15, 2021
BUY
$15.05 - $23.28 $461,177 - $713,369
30,643 Added 73.95%
72,079 $1.29 Million
Q2 2021

Aug 16, 2021
BUY
$15.31 - $24.63 $634,385 - $1.02 Million
41,436 New
41,436 $801,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email